Your browser doesn't support javascript.
loading
Evaluation of the efficacy and safety of the 1064 nm picosecond Nd:YAG laser with a topically applied gold and diamond suspension for facial skin rejuvenation: A pilot study.
Park, Jae Wan; Shin, Sun Hye; Lee, Woo Geon; Li, Kapsok; Seo, Seong Jun; Kim, Chang Hoon; Park, Kui Young.
Afiliação
  • Park JW; Department of Dermatology, Chung-Ang University, College of Medicine, Seoul, South Korea.
  • Shin SH; Department of Dermatology, Chung-Ang University, College of Medicine, Seoul, South Korea.
  • Lee WG; Department of Dermatology, Chung-Ang University, College of Medicine, Seoul, South Korea.
  • Li K; Department of Dermatology, Chung-Ang University, College of Medicine, Seoul, South Korea.
  • Seo SJ; Department of Dermatology, Chung-Ang University, College of Medicine, Seoul, South Korea.
  • Kim CH; Clinical & Regulatory Affairs Team, Simfle-Stick Co. Ltd., Dague, South Korea.
  • Park KY; Department of Dermatology, Chung-Ang University, College of Medicine, Seoul, South Korea.
Dermatol Ther ; 35(6): e15459, 2022 06.
Article em En | MEDLINE | ID: mdl-35304935
ABSTRACT
To investigate the efficacy and safety of combined treatment with a serum comprising a micro-diamond suspension and micro-gold cage with a 1064 nm picosecond neodymium-doped yttrium aluminum garnet (NdYAG) laser for facial skin rejuvenation. Topical serum was applied to the entire face and allowed to penetrate the skin and hair follicles for 20 min. Each participant was then treated with a 1064 nm picosecond NdYAG laser on the face. Photographs of each participant were taken at baseline, immediately after treatment, and 2 weeks after treatment using an imaging tool (Mark-Vu®; PSI PLUS, Suwon, Republic of Korea). Global improvement scores by two blinded investigators and participants' satisfaction scores were also assessed. The melanin index (MI), transepidermal water loss (TEWL), and skin hydration were evaluated using a device. Parameters associated with skin rejuvenation were assessed using Mark-Vu®. Adverse events were observed and reported by participants and physicians during the treatment and follow-up visit. At week 2, 40% (4/10) of the participants showed more than moderate clinical improvement in the investigator's global improvement assessment. No significant differences were observed in the MI, TEWL, skin hydration level, or skin parameters of Mark-Vu®. At week 2, 40% of the participants reported a high satisfaction score and minimal side effects. The novel topical facial serum comprising micro-diamond suspension and micro-gold cage is safe and effective when combined with laser treatment for facial rejuvenation.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Envelhecimento da Pele / Lasers de Estado Sólido Limite: Humans Idioma: En Revista: Dermatol Ther Assunto da revista: DERMATOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Coréia do Sul

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Envelhecimento da Pele / Lasers de Estado Sólido Limite: Humans Idioma: En Revista: Dermatol Ther Assunto da revista: DERMATOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Coréia do Sul